Press Releases - Technology

Press Releases - Technology

October 05, 2020
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into a non-exclusive royalty-bearing license agreement with Abbot
May 13, 2020
New research published in Lab on a Chip demonstrates 100x sensitivity improvement on Simoa; marks significant advancement in sensitivity for industry leading detection platform
May 11, 2020
Test deployed on Quanterix' Ultrasensitive Simoa® platform improves sensitivity and specificity for measuring immune response and seroconversion earlier and with higher resolution
April 24, 2020
Grants will award researchers seeking to harness biomarkers to improve diagnosis, prognosis or treatment efficacy studies with access to Quanterix’ ultra-sensitive detection solutions

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more